The U.S. Food and Drug Administration said on Monday it has approved Egalet Corp's long-acting opioid painkiller, Arymo ER.
Arymo ER is a long-acting variation of morphine that is intended to treat pain severe enough to require daily, around-the-clock, long-term opioid treatment. It comes in the form of a very hard pill that is difficult to crush and otherwise manipulate by people looking to abuse the product.